Effects of Dapagliflozin on Inflammatory Factorslevel and Prognosis in Type 2 Diabetes With Acute Myocardial Infarction
Clinical trial NCT05050500 · COMPLETED
Trial details
- NCT number
- NCT05050500
- Sponsor
- Qingdao Central Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2024-12-30
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.